摘要
背景:Meis1是三氨基酸环延伸(TALE)同源域转录因子的成员。过去十年的研究表明,Meis1在心脏再生,干细胞功能和肿瘤发生中具有重要作用。 目的:我们最近证明敲除成人心肌细胞中的Meis1导致心肌细胞增殖的诱导。这表明靶向Meis1可能被用于心肌损伤后心肌细胞周期的操纵。此外,Meis1的造血干细胞(HSC)特异性缺失导致HSC池的体内扩增。因此,靶向Meis1不仅可导致细胞周期进入,而且还可导致HSC的离体和体内扩增。另一方面,Meis1转录调节低氧肿瘤标志物,即Hif-1α和Hif-2α的表达。 Hif-1α和Hif-2α分别参与细胞质糖酵解和活性氧(ROS)的清除。 结论:研究强调了Meis1在治疗心肌损伤,骨衰竭和癌症方面发展新的治疗方法的新角色。
关键词: Meis1,心脏再生,干细胞扩增,癌症代谢,癌症干细胞。
图形摘要
Current Drug Targets
Title:Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer
Volume: 19 Issue: 2
关键词: Meis1,心脏再生,干细胞扩增,癌症代谢,癌症干细胞。
摘要: Background: Meis1 is a member of three-amino-acid loop extension (TALE) homeodomain transcription factors. Studies in the last decade have shown that Meis1 has crucial roles in cardiac regeneration, stem cell function, and tumorigenesis.
Objective: We have recently demonstrated that knocking out of Meis1 in adult cardiomyocytes resulted in the induction of cardiomyocyte proliferation. This suggests that targeting of Meis1 might be utilized in the manipulation of cardiomyocyte cell cycle post cardiac injuries. In addition, hematopoietic stem cell (HSC) specific deletion of Meis1 leads to in vivo expansion of HSCs pool. Thus, targeting Meis1 may lead to not only cell cycle entry but also ex vivo and in vivo expansion of HSCs. On the other hand, Meis1 transcriptionally regulates the expression of hypoxic tumor markers, namely Hif-1α and Hif-2α. Hif-1α and Hif-2α are involved in the induction of cytoplasmic glycolysis and scavenging of reactive oxygen species (ROS), respectively.
Conclusion: Studies highlight emerging roles of Meis1 towards development of new therapeutic approaches in the treatment of myocardial injuries, bone failure, and cancer.
Export Options
About this article
Cite this article as:
Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer, Current Drug Targets 2018; 19 (2) . https://dx.doi.org/10.2174/1389450118666170724165514
DOI https://dx.doi.org/10.2174/1389450118666170724165514 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cellular Therapy for Heart Failure
Current Cardiology Reviews Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses
Current Drug Targets - CNS & Neurological Disorders Oxidative Stress Modulation Through Habitual Physical Activity
Current Pharmaceutical Design Application of G-CSF in Congestive Heart Failure Treatment
Current Cardiology Reviews Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications
Coronaviruses Adeno-associated Viral Vectors for Correction of Inborn Errors of Metabolism: Progressing Towards Clinical Application
Current Pharmaceutical Design Hybrid Stress Testing by Adenosine Infusion and Exercise Myocardial Perfusion Imaging: A Critical Appraisal
Current Cardiology Reviews Advanced Glycation: How are we Progressing to Combat this Web of Sugar Anomalies in Diabetic Nephropathy
Current Pharmaceutical Design The ABCA2 Transporter: Intracellular Roles in Trafficking and Metabolism of LDL-Derived Cholesterol and Sterol-Related Compounds
Current Drug Metabolism Characteristics Other than the Diagnostic Criteria Associated with Metabolic Syndrome: An Overview
Current Vascular Pharmacology Cardiovascular Molecular Imaging: New Methodological Strategies
Current Pharmaceutical Design Functions of S100 Proteins
Current Molecular Medicine Humoral and Mechanical Cross-Talk in the Vasculature: Perspectives in Vascular Disease
Vascular Disease Prevention (Discontinued) Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?
Current Medicinal Chemistry Magnesium and Anaesthesia
Current Drug Targets Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19
Current Drug Targets Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases
Cardiovascular & Hematological Disorders-Drug Targets The Spatial QRS-T Angle: Implications in Clinical Practice
Current Cardiology Reviews Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure
Current Pharmaceutical Design Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
Current Medicinal Chemistry